You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BAP1 mutation

Showing 1 - 25 of 6,742
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Frequency and Clinical Phenotype of BAP1 Hereditary

Recruiting
  • Uveal Melanoma
  • +7 more
    • Columbus, Ohio
      The Ohio State University Wexner Medical Center
    Jul 6, 2022

    BAP1 Testing in Instance Choroidal Nevi or Uveal Melanoma

    Active, not recruiting
    • Choroidal Nevi, Uveal Melanoma
      • Houston, Texas
      • +2 more
      Mar 24, 2021

      Frequency, Clinical Phenotype and Genetic Analysis of Heritable

      Not yet recruiting
      • Renal Tumor Histology
      • +13 more
      • Gene test
      • Shanghai, Shanghai, China
        Ethics Committee of Shanghai Renji Hospital
      Sep 6, 2022

      Mesothelioma Patients and Their Family Members With Germline

      Recruiting
      • Mesothelioma
      • Families
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 20, 2023

        Mesothelioma, Malignant Mesothelioma (MM), Early-stage Mesothelioma Trial run by the National Cancer Institute (NCI)

        Not yet recruiting
        • Mesothelioma
        • +5 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Aug 1, 2023

        Clear Cell Kidney Cancer, Kidney Cancer, Kidney Cancer With PBRM1/BAP1/VHL/SETD2 Mutations Trial (Axitinib 5 MG)

        Available
        • Clear Cell Kidney Cancer
        • +2 more
        • Axitinib 5 MG
        • (no location specified)
        Jul 3, 2023

        Mesothelioma, Uveal Melanoma, Renal Cell Carcinoma Trial in Gainesville, Miami, Orlando (Niraparib)

        Completed
        • Mesothelioma
        • +3 more
        • Gainesville, Florida
        • +2 more
        Jan 4, 2023

        Healthy Trial in Basel (BAP5191)

        Recruiting
        • Healthy
        • Basel, Switzerland
          Universität Basel Departement Klinische Forschung Ambulantes Stu
        Apr 27, 2023

        AXIN1 Gene Mutation, APC Gene Mutation, Solid Tumor Trial (REC-4881)

        Not yet recruiting
        • AXIN1 Gene Mutation
        • +2 more
        • (no location specified)
        Aug 21, 2023

        Aumolertinib, Anlotinib, TP53 Trial (Aumolertinib,Anlotinib)

        Not yet recruiting
        • Aumolertinib
        • +4 more
        • (no location specified)
        Mar 8, 2023

        Autosomal Dominant Optic Atrophy (ADOA), Caused by OPA1 Mutation

        Not yet recruiting
        • Autosomal Dominant Optic Atrophy
        • +3 more
          • Sydney, Australia
            Sydney Eye Hospital
          Nov 15, 2023

          Gene Mutation Trial in Beijing (RAG-17)

          Enrolling by invitation
          • Gene Mutation
          • Beijing, China
            Beijing Tiantan Hospital
          Jun 11, 2023

          An Intervention to Increase Genetic Testing in Families Who May

          Recruiting
          • BRCA1 Mutation
          • +21 more
          • Intervention Arm At-risk Relative/ARR Contacts
          • +5 more
          • Basking Ridge, New Jersey
          • +7 more
          Nov 22, 2022

          Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Kidney Cancer Trial in Baltimore (Olaparib)

          Recruiting
          • Renal Cell Carcinoma
          • +4 more
          • Baltimore, Maryland
            Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
          Mar 14, 2022

          Solid Tumor, ARID1A Gene Mutation Trial in Greenville (Tazemetostat)

          Suspended
          • Solid Tumor
          • ARID1A Gene Mutation
          • Greenville, South Carolina
            Prisma Health Cancer Institute
          Jan 10, 2023

          Cholangiocarcinoma Non-resectable, Cholangiocarcinoma Metastatic Trial (Ivosidenib)

          Not yet recruiting
          • Cholangiocarcinoma Non-resectable
          • Cholangiocarcinoma Metastatic
          • (no location specified)
          Oct 10, 2023

          Non Small Cell Lung Cancer, Immune Checkpoint Inhibitor, EGFR Exon 21 Mutation Trial in Peking (Pembrolizumab, pemetrexed,

          Not yet recruiting
          • Non Small Cell Lung Cancer
          • +2 more
          • Peking, China
            Peking Union Medical College Hospital
          Nov 16, 2023

          Metastatic Solid Tumor, SF3B1 Gene Mutation, Spliceosome Mutation Trial in Baltimore (Recommendation for treatment with

          Recruiting
          • Metastatic Solid Tumor
          • +4 more
          • Recommendation for treatment with immunotherapy
          • Baltimore, Maryland
            Johns Hopkins University
          Sep 8, 2022

          NSCLC Metastatic Trial in Stockholm (Stereotactic body radiation therapy (SBRT), Temporary Stopping)

          Recruiting
          • Non-small Cell Lung Cancer Metastatic
          • Stereotactic body radiation therapy (SBRT)
          • Temporary Stopping
          • Stockholm, Solna, Sweden
            Karolinska University Hospital
          Nov 9, 2023

          Locally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression = 1% and an STK11

          Recruiting
          • Locally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation
          • Montpellier, France
          • +7 more
          Dec 19, 2022

          Retinal Dystrophy, PRPF31 Mutationassociated Retinal Dystrophy, RP11 Trial in Dallas (VP-001)

          Recruiting
          • Retinal Dystrophy
          • +2 more
          • Dallas, Texas
            Retina Foundation of the Southwest
          Jun 5, 2023

          Advanced Malignant Solid Tumor, EGFR Gene Amplification, EGFR Gene Mutation Trial in Houston (Everolimus, Neratinib,

          Recruiting
          • Advanced Malignant Solid Neoplasm
          • +9 more
          • Houston, Texas
            M D Anderson Cancer Center
          Oct 25, 2022

          Breast Cancer, Genetic Predisposition Trial in Rome, Varese (Genetic predisposition to breast cancer)

          Recruiting
          • Breast Cancer
          • Genetic Predisposition
          • Genetic predisposition to breast cancer
          • Rome, Italy
          • +1 more
          May 4, 2023

          Advanced Solid Tumors Trial (INCB099280, adagrasib)

          Not yet recruiting
          • Advanced Solid Tumors
          • (no location specified)
          Sep 8, 2023

          BRCA1/2 Flu Vaccine

          Active, not recruiting
          • BRCA1 Mutation
          • BRCA2 Mutation
          • Seasonal influenza vaccine
          • Philadelphia, Pennsylvania
            University of Pennsylvania
          Aug 16, 2022